Sort
10,766 grants matching “checkpoint inhibitor”
Project 3: Targeted therapy for splicing factor mutant myeloid malignancies
$355,822Matthew J Walter · Washington University · P50 · FY2024 · CA
Hec1 Network as Molecular Therapeutic Targets
$355,804Wen-Hwa Lee · University Of California-Irvine · R01 · FY2012 · CA
Hec1 Network as Molecular Therapeutic Targets
$355,804Wen-Hwa Lee · University Of California-Irvine · R01 · FY2011 · CA
Melanoma Immunotherapy with GPR182 blockade
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2025 · CA
Melanoma Immunotherapy with GPR182 blockade
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2023 · CA
MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma
$355,706Matthew J Sikora · University Of Colorado Denver · R01 · FY2022 · CA
The GPR171 pathway in cancer immunotherapy
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2023 · CA
The CD93 pathway and melanoma therapy
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2025 · CA
The CD93 pathway and melanoma therapy
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2022 · CA
The GPR171 pathway in cancer immunotherapy
$355,706Yuwen Zhu · University Of Colorado Denver · R01 · FY2025 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$355,698Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
$355,665Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2022 · DK
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
$355,637Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2021 · DK
Determinants of prostate cancer sensitivity to PD-1 blockade
$355,574Lawrence Fong · University Of California, San Francisco · R01 · FY2019 · CA
Cellular and molecular regulators of melanocyte regeneration
$355,520Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AR
The replication checkpoint and genomic fidelity in skin
$355,511Paul Nghiem · University Of Washington · R01 · FY2012 · AR
PDX tumor-TME acquired resistance
$355,505Jack Roth · University Of California, San Francisco · U54 · FY2022 · CA
Mechanisms of Intestinal Tumorigenesis
$355,315Vincent W. Yang · State University New York Stony Brook · R01 · FY2013 · CA
Proj 2 - Exploiting Therapeutic Vulnerabilities
$355,201William A Weiss · Children'S Hosp Of Philadelphia · P01 · FY2021 · CA
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
$355,096Benjamin Izar · Columbia University Health Sciences · U54 · FY2025 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$355,088Cecil Han · Georgetown University · R01 · FY2024 · CA
Therapeutic strategies for targeting PARP1 in small cell lung cancer
$355,019Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$355,019Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2019 · CA
The structural function of ATR in development, oncogenesis and cancer therapy
$355,019Shan Zha · Columbia University Health Sciences · R01 · FY2019 · CA
53BP1-dependent pathway in DNA repair
$355,018Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA